The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A genetic risk-stratified, randomized phase 2 intergroup study of fludarabine/antibody combinations in symptomatic, untreated chronic lymphocytic leukemia (CLL): Results from Cancer and Leukemia Group B (CALGB) 10404 (Alliance).
 
Amy S. Ruppert
No Relationships to Disclose
 
John C. Byrd
Research Funding - Acerta Pharma; Genentech; Pharmacyclics
 
Nyla A. Heerema
Travel, Accommodations, Expenses - Abbott
 
Mitchell Reed Smith
Honoraria - Genentech
Research Funding - Gilead Sciences (Inst); Kite, a Gilead company (Inst); Seagen (Inst)
 
John E. Godwin
Honoraria - Bristol-Myers Squibb
Consulting or Advisory Role - Abbvie/Genentech; Bristol-Myers Squibb
Speakers' Bureau - Abbvie/Genentech; Bristol-Myers Squibb
Research Funding - Bristol-Myers Squibb (Inst); Macrogenics (Inst); MedImmune (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - Abbvie/Genentech; Bristol-Myers Squibb
 
Stephen Couban
No Relationships to Disclose
 
Todd A. Fehniger
Consulting or Advisory Role - Fortress Biotech
Research Funding - Affimed Therapeutics (Inst); Celgene (Inst)
Travel, Accommodations, Expenses - Altor BioScience
 
Michael Thirman
No Relationships to Disclose
 
Alese E. Halvorson
No Relationships to Disclose
 
Martin S. Tallman
Research Funding - Arog (Inst); Cellerant (Inst)
 
Frederick R. Appelbaum
Stock and Other Ownership Interests - Adaptive Biotechnologies; Igenica
Honoraria - Amgen; Celator; National Marrow Donor Program; Neumedicines
Consulting or Advisory Role - Igenica; National Marrow Donor Program
 
Richard M. Stone
Consulting or Advisory Role - Abbvie; Agios; Amgen; Bristol-Myers Squibb; Celator; Celgene; Fujifilm; Juno Therapeutics; Karyopharm Therapeutics; Merck; Novartis; Ono Pharmaceutical; Roche/Genentech; Theradex
Research Funding - Agios (Inst); Celator (Inst); Karyopharm Therapeutics (Inst); Novartis (Inst)
 
Sue Robinson
Honoraria - Roche
Consulting or Advisory Role - Abbvie; Celgene; Janssen; Lundbeck; Roche
Speakers' Bureau - Janssen
 
Julie E. Chang
Research Funding - Celgene (Inst); Genentech (Inst)
 
Sumithra J. Mandrekar
Consulting or Advisory Role - Pfizer; Pique
Other Relationship - Beigene
 
Richard A. Larson
Consulting or Advisory Role - Amgen; ARIAD; Bristol-Myers Squibb; Celgene; CVS Caremark; Jazz Pharmaceuticals; Novartis
Research Funding - Amgen (Inst); Astellas Pharma (Inst); Celgene (Inst); Daiichi Sankyo (Inst); ERYTECH Pharma (Inst)